Genetic variations of APOE and KIBRA have been associated with human memory and Alzheimer's disease. APOE and KIBRA can jointly modulate glutamate receptor to influence long-term potentiation; however, their interactions on brain functional connectivity remain unknown. Here, we investigated additive and epistatic interactions between APOE and KIBRA (rs17070145) on brain functional connectivity density (FCD) in 267 healthy young adults. A voxel-based FCD analysis was performed to identify brain regions with significant APOE-KIBRA interaction. Additive effects showed decreased FCD in the left parahippocampal gyrus and the right middle temporal gyrus and increased FCD in the bilateral middle occipital gyri, with the increase of the number of the risk-alleles of APOE and KIBRA. Epistatic effects showed APOE × KIBRA interaction in the FCD of the dorsolateral prefrontal cortex (DLPFC). The FCD of the DLPFC showed APOE risk-allele-dependent reduction (ε2 > ε3 > ε4) in KIBRA TT homozygotes, but APOE risk-allele-dependent increase (ε2 < ε3 < ε4) in KIBRA C-carriers. FCD differences were only significant between the 2 extreme subgroups in both additive and epistatic analyses. These findings suggest that APOE and KIBRA have region-dependent additive and epistatic interactions on brain connectivity in healthy young adults.
Introduction
Human memory and Alzheimer's disease (AD) are both polygenic phenotypes with complex inheritance patterns (Gatz et al. 2006; Papassotiropoulos and de Quervain 2011) . The additive model can explain only a small portion of heritability of these complex traits, which is referred to as the missing heritability. The missing heritability may be related to gene-gene interaction, gene-environment interaction and phenotypic heterogeneity. The epistasis refers to the combinatorial effect of genetic variants (Niel et al. 2015) , which may explain the inconsistent results of a single candidate variant and the missing heritability in the context of gene-gene interaction. The ε4 allele of apolipoprotein E (APOE) constitutes the strongest genetic risk for sporadic AD, whereas single nucleotide polymorphism (SNP) of KIBRA (rs17070145) is also associated with human memory (Papassotiropoulos et al. 2006; Kauppi et al. 2011; Milnik et al. 2012; Franks et al. 2014; Muse et al. 2014; Schwab et al. 2014; Vogt-Eisele et al. 2014; Boraxbekk et al. 2015; Witte et al. 2016 ) and AD (RodriguezRodriguez et al. 2009; Corneveaux et al. 2010; Burgess et al. 2011; Kawai et al. 2015) . Thus, investigation on the APOE-KIBRA interactions may help to understand complex inheritance of human memory and AD.
Because genetic variations affect phenotypes (i.e., memory or AD) via modulating the structure and function of the brain, investigation of genetic effects on brain properties may provide valuable information on the pathway of gene-brain-behavior (disease) (Tian et al. 2013; Zhang P et al. 2015) . Following this idea, many studies have investigated the effects of genetic variant of APOE or KIBRA on brain structure and function and reported significant effects in cognitive-related brain regions in various populations including healthy young adults (Golby et al. 2005; Papassotiropoulos et al. 2006; Filippini et al. 2009; Honea et al. 2009; Corneveaux et al. 2010; Kauppi et al. 2011; Alexander et al. 2012; Canu et al. 2012; Milnik et al. 2012; Dean et al. 2014; Muse et al. 2014; Boraxbekk et al. 2015; Hafkemeijer et al. 2015; Witte et al. 2016) . Although biological mechanisms underlying the association between APOE and KIBRA pathways are unclear, both SNPs have found to reduce long-term potentiation (LTP), a process related to synaptic plasticity and memory formation (Lynch 2004) by affecting glutamate receptor function (Chen et al. 2010; Makuch et al. 2011) . These findings indicate possible APOE-KIBRA interactions on brain imaging phenotypes.
Resting-state functional connectivity (rsFC) measures temporal coherence of blood oxygenation-level dependent (BOLD) signals between every 2 regions or voxels and shows an estimated heritability of 0.42-0.6 (Glahn et al. 2010; van den Heuvel et al. 2013) . In contrast to the seed-based rsFC analysis that assesses connectivity of the seed region, the functional connectivity density (FCD) mapping is a newly developed datadriven method to assess connectivity of each voxel throughout the whole brain (Tomasi and Volkow 2011) . The FCD analysis provides a promising method to identify brain regions that exhibit APOE-KIBRA interactions on brain connectivity without a priori hypothesis. In this study, we aimed to investigate both additive and epistatic APOE-KIBRA interactions on brain FCD in healthy young subjects, which may facilitate our understanding of genetic complexity of human memory and AD.
Materials and Methods

Subjects
A total of 323 right-handed healthy young subjects were recruited. Participants were carefully screened to ensure that they had no history of psychiatric or neurological illness, psychiatric treatment, or drug or alcohol abuse, and had no contraindications for MRI examinations. Only Chinese Han subjects were included to purify the sample. After a complete description of the study, all subjects provided written informed consent. The protocol was approved by the Ethics Committee of Tianjin Medical University. The visual reproduction test (VRT) in Chinese Revised Wechsler Memory Scale was used to assess episodic memory, and the percentage of perseverative errors (Rpe%) in Wisconsin Card Sorting Test was used to assess executive function. Fifty-six subjects were excluded from further analysis because of genotyping failure (24 subjects), APOE ε2-ε4 genotype (3 subjects, unable to determine the genetic risk), poor imaging quality (imaging artifacts and structural anomalies, 13 subjects) and excessive head movement during the functional magnetic resonance imaging (fMRI) examinations (16 subjects). The remaining 267 healthy young adults were ultimately included in the imaging analysis.
Genotyping
We extracted genomic DNA from 3000 μL of whole blood using the EZgeneTM Blood gDNAMiniprep Kit (Biomiga Inc., San Diego, CA, USA). Then, we genotyped the KIBRA rs17070145 and APOE allele status (rs429358 and rs7412) in each subject using the PCR and ligation detection reaction method (Thomas et al. 2004; Yi et al. 2009 ) with technical support from the Shanghai Biowing Applied Biotechnology Company.
Genotypic Subgroups
To test epistatic effects, we created 6 gene-gene cohorts based carrying statuses of KIBRA rs17070145 and APOE. The distribution of KIBRA rs17070145 genotype (13 CC homozygotes; 99 CT heterozygotes; and 155 TT homozygotes) was consistent with previous reports of variation in this gene in Asia population (Wang D et al. 2013; Wang HF et al. 2013; Kawai et al. 2015) , which showed a lower frequency of CC homozygotes compared to Caucasians (Papassotiropoulos et al. 2006 ). According to genotypes of KIBRA rs17070145, these subjects were divided into 2 groups (112 C-carriers and 155 TT homozygotes); this method has been used previously to address skewed genotypic distributions (Wang D et al. 2013) . For each of the 2 groups, subjects were further divided into ε2-carriers (ε2ε2 + ε2ε3), ε3 homozygotes, and ε4-carriers (ε3ε4 + ε4ε4) based on APOE allele status.
To test for additive effects, we created 3 gene-gene cohorts based on the number of the risk alleles in KIBRA rs17070145 and APOE. Participants with neither KIBRA C-allele nor APOE ε4-allele (zero risk allele) were classified into the "1 low risk group" (TT + ε2ε2 or ε2ε3 or ε3ε3); participants with either a Callele or an ε4-allele (1 risk allele) were classified into the "2 middle risk group" (CT + ε2ε2 or ε2ε3 or ε3ε3; and TT + ε3ε4); and participants with more than two risk alleles were classified into the "3 high risk group" (CC; CT + ε3ε4 or ε4ε4; and ε4ε4).
Image Acquisition
MR images were acquired using a Signa HDx 3.0 Tesla MR scanner (General Electric, Milwaukee, WI, USA). Tight but comfortable foam padding was used to minimize head motion and ear plugs were used to reduce scanner noise. Resting-state fMRI data were obtained using the single-shot echo-planar imaging with the following parameters: repetition time (TR)/echo time (TE) = 2000/30 ms; field of view (FOV) = 240 × 240 mm; matrix = 64 × 64; flip angle (FA) = 90°, slice thickness = 4 mm; no gap; 40 interleaved transversal slices; and 180 volumes. During the fMRI scans, all subjects were instructed to keep their eyes closed, to move as little as possible, to think of nothing in particular and not to fall asleep. After the scan, subjects' conditions were checked to confirm whether they satisfied the requirements. If not, the fMRI data were abandoned and scanned again. Sagittal 3D T1-weighted images were acquired by a brain volume sequence (TR/TE = 8.1/3.1 ms; inversion time = 450 ms; FA = 13°; FOV = 256 × 256 mm; matrix = 256 × 256; slice thickness = 1 mm, no gap; and 176 sagittal slices). All images were carefully checked slice by slice for imaging artifacts and anatomical abnormalities.
FCD Analysis
All preprocessing steps for the resting-state fMRI data were performed using SPM8 (www.fil.ion.ucl.ac.uk/spm). The first 10 volumes of each subject were discarded for signal instability and the participants to adapt the scanning noise. The remaining 170 volumes were corrected for acquisition time delay between slices. All the finally included 267 subjects were within the defined motion thresholds (translational or rotational motion parameters lower than 2 mm or 2.0°). We also calculated the framewise displacement (FD), which indexes volume-to-volume changes in head position (Power et al. 2012) . Because recent studies have reported that signal spike caused by head motion significantly contaminated the final resting-state fMRI results even after regressing out the realignment parameters (Power et al. 2012) , we removed spike volumes if the FD of a volume exceeded 0.3. Several nuisance covariates (6 motion parameters, their first time derivation and average BOLD signals of the ventricular and white matter) were regressed out from the data. The datasets were band-pass filtered with a frequency range of 0.01-0.08 Hz. Individual structural images were linearly co-registered to the mean functional image; then, the structural images were linearly co-registered to the Montreal Neurological Institute (MNI) space. Finally, the filtered functional volumes were spatially normalized to the MNI space using the same co-registration parameters and resampled into a 3-mm cubic voxel.
The FCD of each voxel was calculated using the script written in Linux platform according to the previously described method (Tomasi and Volkow 2011) . The Pearson's linear correlation was used to calculate functional connections, 2 voxels with a correlation coefficient of r > 0.6 were considered functionally connected (Tomasi and Volkow 2011) . This threshold was proposed to be the most optimal threshold for calculating FCD (Tomasi and Volkow 2011) . A gray matter (GM) mask was used to restrict the calculation of the FCD to voxels in the GM regions with a signal-to-noise >50 to minimize unwanted effects from susceptibility-related signal-loss artifacts (Tomasi and Volkow 2011) . The FCD of a given voxel x0 was defined as the total number of functional connections, k(x0), between x0 and all other voxels. This calculation was repeated for all x0 voxels in the brain. The grand mean scaling of FCD was performed by dividing by the mean value of the qualified voxels of the whole brain. After grand mean scaling, the FCD values conformed to normal probability distribution (z = 0.92, P = 0.368) and were suitable for the parametric statistical inference. Finally, the FCD maps were spatially smoothed using a Gaussian kernel of 8 × 8 × 8 mm 3 full-width at half-maximum (FWHM).
Statistical Analyses
Group differences regarding demographics and behavioral data were examined using analysis of variance for continuous data and Chi-square test for categorical data. All analyses were performed using SPSS1 18.0 software package. Significance level was set at P < 0.05 with two-tailed tests.
A full factorial analysis of covariance (ANCOVA) was used to assess APOE × KIBRA epistatic interaction and a linear regression was used to assess additive interaction on FCD while controlling for the effects of gender, age, educational years, and FD values. Multiple comparisons were corrected using Monte Carlo simulation, resulting in a corrected threshold of P < 0.05 and a cluster size of at least 68 voxels for the epistatic interaction and 46 voxels for the additive interaction (AlphaSim program, parameters: single voxel P = 0.01, 5000 simulations, FWHM = 8 mm, cluster connection radius r = 5 mm; with a GM mask and a resolution of 3 × 3 × 3 mm 3 ). Because these genotypic subgroups had unbalanced sample sizes, we repeated voxel-wise analysis (the same voxel-wise statistical threshold of P < 0.01) using nonparametric permutation (10 000 times) test to validate these interaction effects. The permutation tests were performed using the Randomise tool of FSL (http://fsl.fmrib.ox.ac. uk/fsl/fslwiki/randomise/). In the "post hoc" analysis of the additive effects, the Bonferroni method was used to correct for multiple comparisons for each cluster (P < 0.05/3 = 0.016). Considering the unbalance sample sizes of the 6 genotypic subgroups for the epistatic analysis, a bootstrap sampling method was used to investigate the statistical stability of FCD differences between each pair of the genotypic subgroups. For each comparison pair, we considered the group with fewer subjects as a reference, and randomly selected the equal number of subjects from the group with more subjects. A two-sample t-test was used to compare the FCD differences between the 2 subgroups with new sample size while controlling for age, gender, and education years. These steps were repeated for 10 000 times. We computed the repeatability significant percentage (RSP) for each pair of comparison. RSP represents the percentage of successful detecting the intergroup differences from the 10 000 random samplings. The successful detection meant that the resampled test should have a significance of P < 0.05 and have the same sign as the original intergroup difference. RSP >95% was defined as the threshold of statistical significance. For brain regions exhibiting significant additive or epistatic interaction between APOE and KIBRA, we performed power analysis using G*Power 3 software (Version 3.1.9.2, program written by University Kiel, Germany) (Supplementary Materials).
Results
Demographic and Genetic Characteristics
A total of 267 healthy young Chinese Han subjects with highquality imaging data and KIBRA and APOE genotypic information were finally included in this study. The observed genotypic distributions of both SNPs were in Hardy-Weinberg equilibrium (P > 0.05). The demographic and behavioral data are summarized in Table 1 (for the additive analysis) and Table 2 (for the epistatic analysis). Among the 3 subgroups for the additive analysis, there were no significant differences in age (F = 0.051, P = 0.950), sex (χ 2 = 1.078, P = 0.583), years of education (F = 0.097, P = 0.907), FD (F = 0.361, P = 0.697), VRT (F = 0.622, P = 0.538), and Rpe% (F = 0.224, P = 0.799). Among the 6 subgroups for the epistatic analysis, there were no significant main effects of 2 genotypes on age (F = 3.676, P = 0.056 for KIBRA and F = 0.752, P = 0.472 for APOE), years of education (F = 3.028, P = 0.083 for KIBRA and F = 0.471, P = 0.625 for APOE), FD (F = 0.743, P = 0.393 for KIBRA and F = 0.184, P = 0.832 for APOE), VRT (F = 0.426, P = 0.515 for KIBRA and F = 0.440, P = 0.645 for APOE) and Rpe% (F = 0.165, P = 0.685 for KIBRA and F = 0.381, P = 0.683 for APOE). Neither significant interaction effects were found between the 2 genotypes on age (F = 1.580, P = 0.208), years of education (F = 1.407, P = 0.247), FD (F = 1.318, P = 0.270), VRT (F = 0.506, P = 0.604), and Rpe% (F = 0.016, P = 0.984). Chisquare test did not reveal any significant difference in the gender distribution among subgroups in each SNP (χ 2 = 0.100, P = 0.752 for KIBRA and χ 2 = 0.713, P = 0.700 for APOE) and among the 6 subgroups (χ 2 = 2.953, P = 0.707).
Additive Interaction Effects on FCD
Significant APOE-KIBRA additive interactions on FCD (P < 0.05, AlphaSim corrected) were found in the left parahippocampal gyrus (peak MNI coordinates: x = −15, y = −18, z = −24, cluster size = 50 voxels, peak t = −3.60), the right middle temporal gyrus (peak MNI coordinates: x = 51, y = −21, z = −15, cluster size = 81 voxels, peak t = −4.40), and the bilateral middle occipital gyri (left: peak MNI coordinates: x = −39, y = −81, z = 15, cluster size = 149 voxels, peak t = 3.85; right: peak MNI coordinates: x = 45, y = −51, z = −3; cluster size = 249 voxels, peak t = 3.78) (Fig. 1A-D) . The mean FCD values of these 4 clusters were extracted from each subject. The mean and standard error (SE) of the FCD of each cluster of each subgroup are shown in Figure 1E -H. The low risk group (risk-allele = 0) had significantly greater FCD (P < 0.05, Bonferroni corrected) in the left parahippocampal gyrus and the right middle temporal gyrus than the middle (risk-allele = 1) and high (risk-allele > 1) risk groups. However, the low risk group had significantly lower FCD (P < 0.05, Bonferroni corrected) in the bilateral middle occipital gyri than the middle and high risk groups. There were no significant FCD differences in these 4 clusters between the middle and high risk groups (P > 0.05, uncorrected).
Epistatic Interaction Effects on FCD
Significant APOE × KIBRA epistatic interactions on FCD (P < 0.05, AlphaSim corrected) were found in the dorsolateral prefrontal cortex (DLPFC) bilaterally (left: peak MNI coordinates: x = −42, y = 48, z = 15, cluster size = 84 voxels, peak F = 11.01; right: peak MNI coordinates: x = 36, y = 33, z = −3; cluster size = 77 voxels, peak F = 7.60) ( Fig. 2A and B) .
The mean FCD values of these 2 clusters were extracted from each subject. The mean and SE of the FCD of each cluster of each subgroup are shown in Figure 2C and D. In KIBRA TT homozygotes, the FCD values of both clusters reduced with the increase of the risk of APOE allele status (i.e., ε2-carriers < ε3 homozygotes < ε4-carriers); however, in the KIBRA C-carriers, the FCD values increased with the increase of the risk of APOE allele status (i.e., ε2-carriers > ε3 homozygotes > ε4-carriers). The post hoc comparisons showed that APOE ε2-carriers exhibited a greater FCD than ε4-carriers in KIBRA TT homozygotes (left DLPFC: RSP = 99.89%; right DLPFC: RSP = 99.92%), but a lower FCD in KIBRA C-carriers (left DLPFC: RSP = 100%; right DLPFC: RSP = 97.77%). There were no significant FCD differences in the DLPFC between any other contrasts (RSP <95%).
Validation for Voxel-wise Results
The voxel-wise results derived from nonparametric permutation test are shown in Supplementary Figures S1-S4 and Supplementary Tables S1 and S2. These results were very similar to those of parametric ANCOVA and linear regression. Details please see Supplementary Results.
Power Analysis
For each cluster with significant interaction effect, the results of power analysis are shown in Supplementary Tables S3-S6 . For brain regions with significant additive interaction, the powers of post hoc comparisons were greater than 0.9 except for one comparison (power = 0.77). For brain regions with significant epistatic interaction, the powers of 3/4 comparisons were lower than 0.8. Although the powers of voxel-wise analytic methods were large enough when taking the total sample into consideration, they were less than 0.8 when using the minimum sample size (minimum group size × number of groups) to calculate powers. Details please see Supplementary Results.
Discussion
Additive Effects Between APOE and KIBRA We found APOE-KIBRA additive effects in the parahippocampal and middle temporal cortices, manifesting reduced FCD in riskallele-carriers than in non-carriers. These regions are those exhibiting early amyloid deposits (pathologic feature of AD) (Braak and Braak 1991) and structural atrophy (Echavarri et al. 2011) in AD and are the atrophied regions in adults with a family history of AD (Honea et al. 2010 ). In single candidate SNP studies, APOE ε4-carriers show more significant structural atrophy in these regions than non-carriers in AD patients (Canu et al. 2012 ), elder- (Honea et al. 2009 ) and middle-aged adults (Alexander et al. 2012) , and infants (Dean et al. 2014) . Moreover, KIBRA C-carriers showed more severe structural atrophy in cognitive-related regions than TT homozygotes in young adults (Wang D et al. . Low risk group represents subjects without any risk-allele (i.e., neither KIBRA C-allele nor APOE ε4-allele); middle risk group represents subjects with one risk allele (i.e., either C-allele or ε4-allele); and high risk group represents subjects with more than two risk alleles. FCD, functional connectivity density; L, left; MOG, middle occipital gyrus; MTG, middle temporal gyrus; PHG, parahippocampal gyrus; R, right. 2013). These findings suggest that longstanding risk-alleleassociated structural damage may increase vulnerability in these regions in AD. Our findings extend this inference into FCD, although some studies show increased functionality in AD riskallele-carriers (Papassotiropoulos et al. 2006; Filippini et al. 2009 ). The occipital cortex is one of the brain regions that exhibit early amyloid deposits in elderly subjects (Braak and Braak 1991) . Although the occipital cortex has received less attention in the context of AD, several studies show structural and functional impairments in this region in AD (Golby et al. 2005; Hafkemeijer et al. 2015) . In consistent with the increased gray matter volume in the occipital cortex in APOE ε4-carriers compared to non-carriers (Alexander et al. 2012) , we found a riskallele-dependent FCD increase in the occipital cortex. Although the biological significance of FCD and volume increases is unclear, it may represent a compensatory change of the occipital cortex in response to structural and functional impairments in other regions in risk-allele-carriers.
Epistatic Effects of APOE and KIBRA
The epistasis is another kind of gene-gene interaction, which may contribute to the missing heritability of complex phenotypes. In this study, we found a significant APOE × KIBRA epistatic interaction on the FCD of the DLPFC, a brain region showing structural, functional, and connectivity alterations in AD (Grady et al. 2001; Allen et al. 2007; Kaufman et al. 2010; Henigsberg et al. 2011; Wang et al. 2014) . The effects of AD-related genetic variations on structural and functional properties of the DLPFC have been reported in previous studies (Wishart et al. 2006; Fan et al. 2010; Zhang X et al. 2015) . In healthy young adults, BIN1 (an AD-related SNP) risk-allelecarriers show lower functional connectivity between the hippocampus and the DLPFC (Zhang X et al. 2015) . In healthy elderly subjects, APOE ε4-carriers demonstrate reduced cortical thickness in the DLPFC than ε2-carriers (Fan et al. 2010) . In cognitively intact adults, APOE ε4-carriers display increased brain activation in the right DLPFC during working memory task than ε3 homozygotes (Wishart et al. 2006) . In healthy young adult, CLU risk-allele has been related to increased activation in the right DLPFC (Lancaster et al. 2015) . These findings support that the DLPFC is a potential target of AD-related genetic variations.
In KIBRA TT homozygotes, APOE ε4-carriers showed significant FCD reduction than ε2-carriers. This finding is in agree with a traditional hypothesis that APOE ε2 is a protective genotype of AD and APOE ε4 is a risk genotype, which is supported by the reduced volume, cortical thickness, metabolism, connectivity and activation in APOE ε4-carriers than in noncarriers (Frank et al. 2011; Nichols et al. 2012; Evans et al. 2014) . However, in KIBRA C-carriers, APOE ε4-carriers showed significant FCD increase than ε2-carriers, which is consistent with the increased activation in APOE ε4-carriers than in non-carriers (Wierenga et al. 2010; Trachtenberg et al. 2012; Chen et al. 2013; Suri et al. 2015) . The APOE-KIBRA epistatic interaction found in this study may explain for the inconsistent findings in brain activation between APOE genotypes. Moreover, this epistatic interaction may at least partly account for the inconsistent findings of associations of APOE and KIBRA with human memory and AD. For example, the association between KIBRA polymorphism and memory (Papassotiropoulos et al. 2006; Kauppi et al. 2011; Milnik et al. 2012; Franks et al. 2014; Muse et al. 2014; Schwab et al. 2014; Vogt-Eisele et al. 2014; Boraxbekk et al. 2015; Witte et al. 2016 ) and AD (Rodriguez-Rodriguez et al. 2009; Corneveaux et al. 2010; Burgess et al. 2011; Kawai et al. 2015) have obtained inconsistent findings. Similarly, although APOE ε4 is considered as the strongest genetic risk for AD, only a portion of APOE ε4-carriers would develop into AD and some APOE ε4-non-carriers could also suffer from AD. Therefore, this epistasis should be carefully considered in future imaging genetics studies on AD-related risk genes.
Region-dependent Interaction Between APOE and KIBRA In this study, we found a region-dependent interaction between APOE and KIBRA. For example, the additive interaction was present in temporal and occipital regions, whereas the epistatic interaction was present in the prefrontal regions. Even in the additive effect, the temporal cortex showed risk-alleledependent FCD reduction, but the occipital cortex exhibits riskallele-dependent FCD increase. These findings may reflect the complexity in the effects of AD-related genetic variants on the brain. First, the same SNP usually has a region-specific, that is, having a stronger effect on some brain regions, but a weaker effect on other regions. Second, different SNPs may target on different brain regions or show the varying degree influence on the same region. Third, one brain region impairment may lead to structural and functional alterations in other regions because they are closely interconnected. Fourth, the structural impairment of a brain region may induce plastic changes in itself and other regions because the brain is lifetime plastic. For brain regions with significant genetic effects, future studies should differentiate primary from secondary impairments and compensatory from maladaptive plasticity.
Possible Biological Mechanisms Underlying APOE-KIBRA Interactions
Although the biological mechanisms underlying the APOE-KIBRA interactions on brain FCD are unclear, these two SNPs have been associated with the LTP, which is a mechanism of synaptic plasticity associated with learning and long-term memory formation (Lynch 2004 ). The LTP is thought to be express partly by a persistent modification of postsynaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors (AMPAR), an ionotropic transmembrane receptor for glutamate. The KIBRA plays an important role in the regulation of AMPAR trafficking through binding to PICK1 (protein interacting with C-kinase 1) (Makuch et al. 2011; Schwab et al. 2014) . The N-methyl-D-aspartate receptor (NMDAR) is another ionotropic glutamate receptor, the expression of which is modulated by APOE (Chen et al. 2010; Yong et al. 2014) . The function of NMDAR is closely associated with AMPAR activation (Unoki et al. 2012) , which may establish a link between KIBRA and APOE. One candidate explanation for the complex APOE-KIBRA interactions on brain FCD may be the differential effects of genetic variations in APOE and KIBRA on the LTP of memoryrelated brain regions. However, the cellular and molecular mechanisms underlying associations of APOE and KIBRA with human memory and AD are far from clear and deserve to be clarified in future studies.
Limitations
Several limitations should be noted in this study. First, although both parametric and nonparametric voxel-wise analyses have obtained similar results, power analysis has shown the lack of enough powers in some statistical comparisons since the sample sizes were rather small in some genotypic subgroups. In imaging genetics studies, unbalanced samples are common. In this case, a much larger sample should be collected to guarantee enough sample size in the minimum genotypic subgroup to improve the power of statistical analysis. Second, we only recruited healthy young adults. It should be determined whether the APOE-KIBRA interactions on brain connectivity are also present in cognitively intact older adults or AD patients. Third, we only focused on the measure of FCD. Future studies should test whether APOE-KIBRA interactions are also present in other imaging measures. Finally, we only focused on the effects of APOE and KIBRA, which are only two of multiple AD-related genes. Much work is needed to explore gene-gene interactions among other AD-related genes.
Conclusion
In this study, we found both additive and epistatic interactions between APOE and KIBRA on FCD in healthy young adults. Additive effects were present in the temporal and occipital regions with reverse risk-allele-dependent effects. Epistatic effects were found in the DLPFC exhibiting an opposite APOE risk-allele-dependent effects in different KIBRA genotypes. The APOE-KIBRA interactions may partly explain for the missing heritability in the complex phenotypes of human memory and AD.
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